about
Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancerThe multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells.A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectumThe treatment of metastatic non-small cell lung cancer in a new era of personalized medicine.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Maintenance therapies for non-small cell lung cancer
@ast
Maintenance therapies for non-small cell lung cancer
@en
Maintenance therapies for non-small cell lung cancer
@nl
type
label
Maintenance therapies for non-small cell lung cancer
@ast
Maintenance therapies for non-small cell lung cancer
@en
Maintenance therapies for non-small cell lung cancer
@nl
prefLabel
Maintenance therapies for non-small cell lung cancer
@ast
Maintenance therapies for non-small cell lung cancer
@en
Maintenance therapies for non-small cell lung cancer
@nl
P2860
P356
P1476
Maintenance therapies for non-small cell lung cancer
@en
P2093
Elie Kassouf
Normand Blais
P2860
P356
10.3389/FONC.2014.00213
P407
P577
2014-01-01T00:00:00Z